Evidence map›Paper›PMID 35285860›Full record

ArticleTranslational vision science & technology2022

Zebrafish: An In Vivo Screening Model to Study Ocular Phenotypes.

Wim H Quint, Kirke C D Tadema, Johan H C Crins, Nina C C J Kokke, Magda A Meester-Smoor, Rob Willemsen, Caroline C W Klaver, Adriana I Iglesias

Open access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Wim H QuintDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands.
Kirke C D TademaDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands.
Johan H C CrinsDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands.
Nina C C J KokkeDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands.
Magda A Meester-SmoorDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands.
Rob WillemsenDepartment of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands.
Caroline C W KlaverDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands.
Adriana I IglesiasDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands.
Erasmus MC · NLRadboud University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To establish a set of assays that allow the in vivo screening of candidate genes for ocular diseases in zebrafish, with an emphasis on refractive error. Methods: Our pipeline includes the most relevant ocular screening measurements to assess (1) ocular biometry using spectral domain optical coherence tomography, (2) refractive status using an eccentric photorefractor, (3) intraocular pressure by tonometry, and (4) optokinetic response to study visual capability in zebrafish. To validate our pipeline and to demonstrate the potential of zebrafish as a valid animal model, we chose two well-characterized genes with an ocular phenotype (PRSS56 and FBN1) and generated two mutant zebrafish lines (prss56 and fbn1). Mutant fish were assessed at 2, 4, and 6 months after fertilization. Results: With the proposed phenotyping pipeline, we showed that ocular biometry, refractive status, intraocular pressure, and visual function can be studied in zebrafish. In the prss56 mutant, the pipeline revealed a dramatic decrease in axial length, mainly owing to a decreased vitreous chamber depth, whereas in the fbn1 mutant, ectopia lentis was the most distinctive ocular phenotype observed. Tonometry in both mutant lines showed an increase in intraocular pressure. Conclusions: The proposed pipeline was applied successfully in zebrafish and can be used for future genetic screenings of candidate genes. While validating our pipeline, we found a close resemblance between the ocular manifestations in the zebrafish mutants and patients harboring mutations in PRSS56 and FBN1. Our results support the validity of our pipeline and highlight the potential of zebrafish as an animal model for in vivo screening of candidate genes for ocular diseases.

Indexed as

Ectopia LentisZebrafishAnimalsDisease Models, AnimalEyeFibrillin-1HumansPhenotypeSerine ProteasesFibrillin-1PRSS56 protein, humanSerine Proteases

Identifiers

PMID35285860
PMCPMC8934544
OpenAlexW4220775769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.